| # | % | |||||
|---|---|---|---|---|---|---|
| 201 | NUVEEN TX ADV TOTAL RET STRG | 12,200 | 165,000 | 0.00% | ||
| 202 | EATON VANCE LTD DURATION INC | 10,528 | 151,000 | 0.00% | ||
| 203 | MONARCH CMNTY BANCORP INC COM | 50,000 | 151,000 | 0.00% | ||
| 204 | PRUDENTIAL BANCORP INC NEW | 11,055 | 140,000 | 0.00% | ||
| 205 | COVISINT CORP | 61,920 | 126,000 | 0.00% | ||
| 206 | CALAMOS STRATEGIC TOTL RETN | 10,200 | 115,000 | 0.00% | ||
| 207 | VERSUS TECHNOLOGY INC COM | 171,550 | 17,000 | 0.00% | ||
| 208 | ENZON PHARMACEUTICALS INC | 10,000 | 11,000 | 0.00% | ||
| 209 | ROCK CREEK PHARMACEUTICALS INCORPORATED | 96,100 | 10,000 | 0.00% | ||
| 210 | INTERNATIONAL STEM CELL CORP C | 42,000 | 2,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001134283-15-000010, filed 2015.05.04).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
